The DEA needs way more marijuana and mushrooms in 2022 to do research! The interest in marijuana globally isn’t rescinding anytime soon. This has birthed confidence in the hearts of marijuana enthusiasts that it may lead to more research and possibly federal legalization. Well, such hopes for legalization steam from news like this: the DEA wanting more cannabis and psychedelics for research in the coming year 2022. The DEA calling for a mass increase in production The Drug Enforcement Administration has made an official call for a dramatic increase in research-based psychedelics and cannabis production for 2022. In a report by Marijuana Moment, the Federal agency will declare its interest in a notice scheduled for publication on Monday that has become the topic of interest within the cannabis industry. The DEA has already increased its 2021 quota for psilocybin and cannabis in September 2021 but is now calling for an even larger quantity of research-grade cannabis with a broader array of psychedelics for production in 2022. A plan to double the number of cannabis extracts, psilocin and psilocybin, quadruple mescaline, and quintuple DMT is in the works, and the most outstanding is MDMA.

420 Intel – Marijuana Industry News, 11/08/2021 19:00:00

Open article: